EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The chemotherapy of onchocerciasis 10. an assessment of 4 single dose treatment regimes of mk 933 ivermectin in human onchocerciasis






Annals of Tropical Medicine and Parasitology 79(1): 63-78

The chemotherapy of onchocerciasis 10. an assessment of 4 single dose treatment regimes of mk 933 ivermectin in human onchocerciasis

Patients (19) from an area of vector control in the savanna region of Northern Ghana, all with moderate to heavy infections with Onchocerca volvulus and some with ocular involvement, were treated with 50, 100, 150 or 200 .mu.g/kg of ivermectin. Detailed monitoring of clinical and ocular reactions and of alterations in skin microfilarial counts and laboratory indices were carried out during the first 28 days. Microfilarial counts in skin snips and detailed ocular examinations were then repeated at intervals over a period of 9 mo. Ivermectin slowly eliminated microfilariae from the skin and eye without serious adverse clinical or ocular reactions in all treated groups. There was little difference in efficacy between doses of 100, 150 and 200 .mu.g/kg, and these were more effective than the 50 .mu.g/kg dose. Very low levels of skin microfilariae were maintained for 9 mo. Microfilariae were not eliminated from the eye for at least 3 mo. The drug was neither macrofilaricidal nor embryotoxic. It produced a dose-dependent stimulation of embryogenesis manifest at one month and succeeded by a suppression of embryogenesis at 3 mo. after therapy. In areas where transmission of onchocerciasis was interrupted, ivermectin may need not be given more often than once a year. The efficacy of the drug on single dosage and the mild adverse reactions produced, if confirmed in subsequent controlled studies, would greatly simplify the treatment of onchocerciasis and would reintroduce new concepts of the role of chemotherapy in the control of onchocerciasis.


Accession: 006614103



Related references

The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. Annals of Tropical Medicine and Parasitology 79(1): 63-78, 1985

A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 82(1): 35-47, 1989

The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana. Annals of Tropical Medicine and Parasitology 80(4): 433-442, 1986

Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects. Tropical Medicine and Parasitology 39(1): 19-24, 1988

The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control. Tropical Medicine and Parasitology 40(3): 361-366, 1989

The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics. Tropical Medicine and Parasitology 45(3): 203-208, 1994

Ivermectin-induced immunopotentiation in onchocerciasis: Recognition of selected antigens following a single dose of ivermectin. Clinical and Experimental Immunology 103(2): 244-252, 1996

Ivermectin and human onchocerciasis. A study of 234 onchocerciasis patients in the Republic of Mali. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 81(2): 260-270, 1988

Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus. Transactions of the Royal Society of Tropical Medicine and Hygiene 84(1): 103-108, 1990

Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus. Transactions of the Royal Society of Tropical Medicine and Hygiene 85(2): 267-271, 1991